Reconfigured hybrid imaging lowers radiation exposure

June 11, 2012

Molecular imaging is effective for providing information about disease processes, and today's hybrid imaging systems have additional computed tomography (CT) technology on board for alignment and imaging structures. While this addition increases the amount of radiation dose a patient receives, research presented at the Society of Nuclear Medicine's2012 Annual Meeting finds that multiple molecular imaging studies need only one structural scan, which would slice off a significant amount of patient radiation exposure.

A method of called positron emission tomography (PET) provides information about physiological processes in almost every part of the body. State-of-the-art imaging systems combine PET with CT to add anatomical information that shows precisely where the process is occurring. The addition of CT during studies for one patient can dramatically increase their , but studying brain PET/ have discovered that just one CT scan is enough to support more than one PET scan. Multiple PET scans are sometimes necessary for imaging injected biomarkers that take a long time to bind to their targets, during diagnosticstudies that require pausing or during scans to test new .

"Awareness of medical has increased over the past several years. In particular, the concern of additional radiation dose associated with CT in PET/CT is magnified in scans performed for investigational purposes," says Jae Sung Lee, Ph.D., associate professor of nuclear medicine at Seoul National University, Seoul, Korea.

Radiation is a that is happening all the time as certain materials decay. Every year people are exposed to about 3 mSv (a measurement of exposure to radiation) of natural background radiation that comes from soil, from rocks or from high altitudes, to name some examples. As a comparison, people receive about 2 mSv during an average CT scan of the head.

"Computed tomography is useful for reducing PET scan time and improving image quality, but there is room for reducing the radiation dose—especially in brain PET studies—by avoiding the redundancy of repetitive CT scans," says Lee. "In this study, we propose a scheme to minimize the radiation dose by performing only a single CT scan per each subject and employing an image registration technique between brain PET scans."

During the study, researchers worked with five volunteers who were imaged in two sessions of dynamic brain PET/CT scanning with a new biomarker for amyloid plaque, which is implicated in cognitive decline and Alzheimer's disease. After an intermission during imaging, subjects were placed in a different position and another imaging study was performed. Both studies were 80-90 minutes long. Scientists compared images from the second PET study using the original CT image, the realigned CT image and the second CT to determine if using only the first CT scan was feasible. Researchers concluded that one CT image could be used during multiple PET studies to achieve satisfactory image quality.

Explore further: FDA approval for Siemens PET Scan - MRI combo

Related Stories

FDA approval for Siemens PET Scan - MRI combo

June 13, 2011
(Medical Xpress) -- The Siemens Biograph mMR system, offering both a PET scan and an MRI that work simultaneously, has been given approval by the FDA. The idea behind this machine and the ability to run both tests at the ...

Irregular breathing can affect accuracy of 4-D PET/CT

June 7, 2011
A study presented at SNM's 58th Annual Meeting focuses on the effect that breathing irregularities have on the accuracy of 4D positron emission tomography (PET) scans and outlines a PET imaging method that reduces "motion ...

Experts offer pointers for optimizing radiation dose in pediatric CT

January 6, 2012
An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans. Approximately seven to eight million CT examinations ...

Combining CT, FDG-PET provides more accurate treatments for head and neck cancer patients

April 29, 2011
Combining computerized tomography (CT) with fluorodeoxyglucose positron emission tomography (FDG-PET) images results in significantly more defined tumor outlines and potentially different treatment options in head and neck ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.